Related Experiment Video
Updated: Jun 21, 2026
05:44
Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function
Published on: July 14, 2016
Saccadometry of conditional rules in presymptomatic Huntington's disease
Matthieu P A Robert1, Parashkev C Nachev, Stephen L Hicks
1Department of Clinical Neuroscience, Imperial College, London, United Kingdom. Matthieu.robert06@imperial.ac.uk
Annals of the New York Academy of Sciences
|August 4, 2009
Summary
A new complex eye movement task shows promise for detecting early signs of Huntington
Area of Science:
- Neuroscience
- Ophthalmology
- Genetics
Background:
- Huntington's disease (HD) research seeks early detection markers.
- Subtle preclinical abnormalities in eye movements and cognitive function are known in HD.
- Combining oculomotor tasks with cognitive challenges may improve early detection.
Purpose of the Study:
- To investigate a novel, cognitively demanding saccadic eye movement task for detecting early signs of Huntington's disease.
- To compare the sensitivity of this complex task against simpler saccadic tasks and conventional cognitive tests.
Main Methods:
- Evaluated 12 early-symptomatic HD patients and 17 presymptomatic gene carriers.
- Used three saccadic paradigms: prosaccades, color-cued saccades, and a second-order conditional rule task.
- Recorded eye movements using portable infrared oculography.
Main Results:
- The second-order conditional rule task effectively discriminated between clinical groups.
- This complex task demonstrated predictive potential within the presymptomatic HD group.
- The novel task was more sensitive in detecting abnormalities than simpler saccadic paradigms.
Conclusions:
- A complex oculomotor task combined with portable saccadometry offers a sensitive functional marker for early Huntington's disease detection.
- This approach may be superior to traditional cognitive tests and simpler eye movement tasks for identifying preclinical HD.
- This method holds promise for monitoring disease progression and treatment efficacy.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...